Submit Source Data of Phase III CT Report: CDSCO Panel Tells Eris Lifesciences on Metoprolol Succinate plus Dapagliflozin FDC Dr. Divya Colin11 May 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial report of fixed-dose combination (FDC) drug, Metoprolol Succinate sustained released 25mg/50mg plus...
Dr. Reddy's Laboratories gets CDSCO Panel Nod for BA/BE study of Ketorolac Tromethamine Sustained Release Tablet Dr. Divya Colin10 May 2024 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO Panel grants Zydus Lifscience Proposal For Additional Indication of Trivalent Influenza vaccine in 6 months to 17 years age Dr. Divya Colin9 May 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Zydus Lifscience's...
AstraZeneca says it will withdraw COVID-19 vaccine globally Kajal Rajput8 May 2024 10:28 AM ISTNew Delhi: The vaccine most consumed in India, will soon disappear from the drug shelves of the country as AstraZeneca on Tuesday announced it had...
Biological E Gets CDSCO Panel Nod for Continued Safety study of 14-valent pneumococcal polysaccharide conjugate vaccine Dr. Divya Colin7 May 2024 6:00 PM ISTNew Delhi: The drug major Biological E has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Justify dose and rationality: CDSCO Panel Tells Dr. Reddy's Lab on Sacubitril-Valsartan tablets 25 mg Dr. Divya Colin6 May 2024 6:00 PM ISTNew Delhi: Noting that the proposed protocol is insufficient to prove the clinical relevance of the lower strength of Sacubitril/Valsartan...
Bharat Biotech International Gets CDSCO Panel Nod to Study Mycobacterium Tuberculosis Live Attenuated Vaccine Dr. Divya Colin5 May 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved vaccine major...
Delhi HC slaps Rs 3 lakh fine on drugmaker for violating Pfizer trademark of Viagra Farhat Nasim4 May 2024 11:15 AM ISTDelhi: The Delhi High Court has made a definitive ruling to permanently prohibit the use of the 'Vigoura' mark by a homeopathic drug manufacturer for...
NPPA Revises Ceiling Prices Of Coronary Stents Dr. Divya Colin3 May 2024 6:00 PM ISTNew Delhi: Through a recent notification, after considering the Wholesale Price Index (WPI) at 0.00551% for the year 2023 over 2022, the National...
Justify Rationality of FDC Meropenem plus Sodium Carbonate plus Avibactam: CDSCO Panel Tells Akum Pharmaceutical Dr. Divya Colin2 May 2024 6:00 PM ISTNew Delhi: Reviewing the proposal presented by the drug major Akum Pharmaceutical, the Subject Expert Committee (SEC) functional under the Central...
Alkem Laboratories Gets CDSCO Panel Nod to Study Amoxicillin,Clavulanate Powder for reconstitution into suspension Dr. Divya Colin1 May 2024 6:00 PM ISTNew Delhi: Reviewing the revised Phase IV clinical trial (CT) protocol of antimicrobial drug Amoxicillin Trihydrate plus Potassium Clavulanate powder...
Conduct bridging CT, prove efficacy, safety: CDSCO Panel Tells Glenmark on Roflumilast Cream of additional strength, indication Dr. Divya Colin30 April 2024 6:00 PM ISTNew Delhi: Citing that Glenmark Limited should conduct bridging clinical trials to prove the efficacy and safety of the Roflumilast Cream 0.3%w/w...
